Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
8 The exact pathogenic mechanism of the p.(Cys4058Trp) is currently unknown but the variant affects a cysteine residue that is predicted to form a disulfide bond, stabilizing tertiary protein structure
Injectable peptides like TB-500 should be stored according to manufacturer instructions to maintain stability
While most people experience no significant side effects, some may feel mild discomfort or redness at the injection site
BPC-157 is usually described in relation to gut-derived protective peptides and tissue repair research
BPC-157 and TB-500 operate via distinct but complementary mechanisms BPC-157 primarily through growth factor receptor upregulation and angiogenesis, TB-500 through actin-mediated cell migration and cytoskeletal remodelling
